Quinten Health innovates at DIA Basel 2023 with Real-World Digital Twins for Clinical Trial Optimization

2023, 13 March

| < 1 min read|
Grégoire Dugast
Thumbnail for the article on the Press Release for the Live Session at DIA Europe 2023

We are thrilled to announce that March 23rd, Quinten Health will animate a 𝗟𝗶𝘃𝗲 𝗦𝗲𝘀𝘀𝗶𝗼𝗻 at 𝗗𝗜𝗔 𝗘𝘂𝗿𝗼𝗽𝗲 𝟮𝟬𝟮𝟯.
Billy Amzal, CEO of Quinten Health and Alexandre Templier, President of Quinten Health, will invite industry and regulatory leaders to discuss why and how to extend current clinical evidence with the projection of long-term real-world medical and economic value from R&D stages.

“Our disease and care simulators leverage the best existing data networks/platforms and combine state-of-the-art AI/ML, predictive modeling, and pharmaco-epidemiology. We are building reference ‘virtual twins’ generators in diseases with high unmet needs to accelerate drug development and patient access to the right drugs” comments Dr Billy Amzal, CEO of Quinten Health and a pioneer expert in disease modeling since 1999.

“Our disease-centric models will ultimately transform the way drugs are developed and evaluated, and enable precision care” complements Dr Alexandre Templier, President of Quinten Health.

See the full press release in the link below.




latest articles